Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Malignant Female Reproductive System Neoplasm × Heparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thrombosis 1 Neoplasms 1 Metabolic Diseases 1 Malignant Female Reproductive System Neoplasm 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Catheter-Related Infections 1 Bacteremia 1 Anemia, Aplastic 1

Interventions

Heparin 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356329 2016-05-13

Lovenox

National Guard Health Affairs

Phase 3 Suspended

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡